Login / Signup

Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.

Runhui WuXiaoling WangXielan ZhaoYanli ChengZeping ZhouJing SunMing XuWenqian LiJianwen XiaoFenge YangYun ChenWeiqun XuJing HuangChuanrong MaWenlin GaiLiangzhi XieRenchi Yang
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Omfiloctocog alfa was efficacious and well tolerated for the prevention and treatment of bleeding in Chinese pediatric PTPs with severe hemophilia A.
Keyphrases
  • recombinant human
  • replacement therapy
  • early onset
  • young adults
  • atrial fibrillation
  • drug induced
  • combination therapy
  • childhood cancer